Inventory Control Specialist

**Join Team Inivata**

If making a difference is in your DNA and you are ready to join the liquid biopsy revolution, then you could be just the person we are looking for. We are located in the heart of life sciences in Cambridge, UK and RTP, North Carolina, USA.

In addition to a competitive salary, we offer our team members multiple benefits to help them build their career with us.

**For US Based team members:**

* Medical Insurance including Dental and Vision

* Life Insurance

* Disability Insurance

* Generous 401K

* PTO and holidays

* Discretionary Bonus Scheme

**For UK Based team members:**

* Life Insurance

* A generous pension scheme

* A discretionary bonus scheme

* Private Medical Insurance, with discounts on gym memberships, restaurants and other perks

* Enhanced maternity/paternity benefits

and lots of social events and pizza lunches!

**Were always looking for talent.**

If a relevant role isnt advertised above but you want to let us know you are interested in joining us, please send your resume and a covering letter to [email protected].

**Clive Morris**

**President**

Clive Morris is President at Inivata. Following an early career as a surgeon, Clive worked for over a decade in various key roles at AstraZeneca, where he oversaw R&D and medical affairs projects and groups on a global scale, was involved in R&D strategy, investor relations, and led the major transformation of AstraZenecas UK strategic R&D sites and global HQ.

He has extensive experience across all phases of drug development including seven marketed or close-to-market oncology products. Clive also founded and lead Health Innovation Manchester, and is a non-executive director of Wheatsheaf investments.

Clive is accredited as a Pharmaceutical Medicine specialist by the UK Royal College of Physicians, has an Executive MBA and trained as a physician at the University of Manchester in the UK.

**Charlene Knape**

**SVP, Strategic Programs**

Charlene Knape is SVP, Strategic Programs at Inivata and brings more than 25 years of experience and leadership in key areas including Clinical Affairs, Regulatory Affairs, Quality, Program Management and the Clinical Laboratory. Along her career path Charlene has held positions and executive roles at both start-ups and large corporations, including Kiyatec, Becton Dickinson, Micell Technologies, LabCorp, EndoTex, Somnus, and Avocet, covering a vast array of technologies focused in oncology, cardiovascular medical devices/combination products and the personalized medicine diagnostic space. Throughout her career, Charlene has participated in all levels of program teams bringing novel products to global markets, including USA, EU, and China, while working through multiple regulatory pathways, including FDA PMA/510(k), CE Mark and NMPA (formerly CFDA). Charlene comes from Toronto, Canada and holds a degree in Medical Laboratory Science.

**Peter Collins**

**Chief Business Officer**

Peter Collins is Chief Business Officer at Inivata. Peter brings over 30 years of experience working in the biopharmaceutical sector, having held senior leadership positions in several molecular diagnostics companies, most recently at Guardant Health. Peter has also served as Chief Business Officer of Yourgene Health, where he led all aspects of commercialization and business development. Prior to this, Peter was Vice President, Head of Diagnostics at GSK where he was responsible for the companion diagnostics assets and pipeline across all therapeutic areas, particularly oncology and VP, Pharma Business Development at QIAGEN. Peter was also the founder and board member of Epemed, a European not for profit organisation bringing together global forces in personalized medicine. Peter holds a BSc in Biological Sciences from Plymouth University.

**Alan Schafer PhD**

**Chief Technology Officer**

Alan Schafer is Chief Technology Officer at Inivata. Alan brings to the role over 25 years of genetics and molecular diagnostics experience. He was previously CEO of 14M Genomics, a cancer molecular diagnostics company, and prior to that served as CEO of Population Genetics Technologies, a business specialising in infectious disease diagnostics and next-generation sequencing technologies. Earlier roles include those of Global VP Technology Development at GlaxoSmithKline and VP Genetics at Incyte. More recently, Alan has worked as an independent consultant for the biotechnology industry, academia and the investment community, offering his expertise in genomic and biology technologies with a particular focus on the interface between science, technology and business. Alan holds a PhD from the University of Southern California and has authored numerous publications in the molecular genetics field.

**Robert Osborne**

**SVP, Technology and Assay Development**

Robert Osborne is SVP, Technology and Assay Development at Inivata. Robert has more than 20 years of experience in research and development. Before joining Inivata in April 2019, Robert was a Principal Staff Scientist at the Wellcome Trust Sanger Institute where he developed new approaches to quantitate somatic variants in polyclonal tissues. Previously, he was Director of Technology Development at 14M Genomics and Director of Research at Population Genetics Technologies (PGT). Robert has authored 16 patents, including key early work on molecular barcoding technologies. Robert has a PhD in Genetics from the University of Nottingham and completed postdoctoral fellowships at the University of Rochester, NY and the University of Oxford.

**Jacqui Watson**

**Chief People Officer**

Jacqui Watson is Chief People Officer at Inivata. Jacqui brings an extensive background of working internationally as an HR Director, People Developer, and consultant within various organizations at a senior level. She has over 20 years experience of leading people and business transformation across different sectors including pharma, IT and hospitality.

Throughout her career Jacqui has focussed on inspiring individuals and teams to reach their full potential and in her current role she is responsible for the alignment of our organisational human resource processes to help drive our business success. She was most recently consulting for various companies, where her primary focus was to identify and develop a sustainable supply of leadership and talent from within these organizations.

**Tim Shannon**

**Chief Financial Officer**

Tim Shannon is Chief Financial Officer at Inivata. Tim manages finance, administration and legal activities. Prior to joining Inivata he formulated and implemented financial controls and process improvements supporting business growth and expansion most recently at Baxano Surgical and Talecris Biotherapeutics. His background in technology, life sciences, and distribution environments is particularly relevant as Inivata moves forward towards commercialization.

While at Talecris, Tim managed the Initial Public Offering (IPO) at a $3.28 billion valuation and has managed merger and acquisition transactions. Tim also has operational business experience across critical issues including budgeting, investor relations, systems implementation, and risk management. Tim has a Bachelor of Science in Business Administration from Appalachian State University and is a CPA, having spent the first 15 years of his career with PwC.

**Stacy Chick**

**Chief Commercial Officer**

Stacy brings over 25 years of US healthcare commercial experience to Inivata. Joining the team as a consultant in early 2018, Stacy quickly leveraged her healthcare sales, marketing, market access and operations experience to build and accelerate the commercialization strategy for InVisionFirst-Lung. Stacy was appointed Chief Commercial Officer effective September 1, 2018. Prior to joining Inivata, Stacy held sales, marketing, market access and general management executive roles leading teams in global and US life science companies i